P470: NGS-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PERIPHERAL BLOOD SHOWS GOOD PROGNOSTIC VALUE FOR OS AND EFS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECRUITED IN THE UNIFY TRIAL. (23rd June 2022) - Thiede, C.; Schuster, C.; Krippendorf, C.; Koenen, G.; Medts, T.; Marques Ramos, P.; Gou, L.; Montesinos, P.; Fiedler, W.; Müller, R.; Krauter, J.; Sica, S.; et al.